New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2012
18:01 EDTMDRXAllscripts concludes evaluation of strategic alternatives
Commenting on the strategic alternatives process, Mr. Chookaszian, Allscripts Chairman of the Board, stated: "The Board conducted a thorough and rigorous review of strategic alternatives. The Board concluded, however, that the best course at this time is to develop Allscripts' long-term potential under the direction of our new management team." Incoming Chief Executive Officer, Mr. Black said, "I look forward to building on the many successes achieved by the Allscripts team. Without underestimating the challenges ahead, we have compelling open-platform solutions, an impressive global client base, and a very dedicated and talented team. We will improve the execution of our strategic vision, deliver on our worldwide client commitments, and continue to innovate. Our focus will be on creating long-term value for our shareholders."
News For MDRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 31, 2015
16:23 EDTMDRXGlenhill Advisors reports 5.3% stake in Allscripts
Subscribe for More Information
August 25, 2015
16:03 EDTMDRXCookeville Medical Center selects Allscripts for CCM program
Subscribe for More Information
August 24, 2015
09:45 EDTMDRXOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Bank of America (BAC) upgraded to Outperform from Market Perform at Keefe Bruyette... Bristol-Myers (BMY) upgraded to Neutral from Underweight at Piper Jaffray... Chevron (CVX) upgraded to Neutral from Underperform at BofA/Merrill... Abercrombie & Fitch (ANF) upgraded to Overweight from Neutral... Nike (NKE) upgraded to Outperform from Market Perform at Telsey Advisory... DreamWorks (DWA) upgraded to Buy from Neutral at B. Riley... Caesarstone (CSTE) upgraded to Overweight from Equal Weight at Barclays... TransAlta (TAC) upgraded to Outperform from Market Perform at BMO Capital... Sarepta (SRPT) upgraded to Overweight from Neutral at Piper Jaffray... AutoZone (AZO) upgraded to Buy from Neutral at BofA/Merrill... Royal Dutch Shell (RDS.A) upgraded to Buy from Hold at Jefferies... Allscripts (MDRX) upgraded to Buy from Hold at Argus... China Unicom (CHU) upgraded to Buy from Hold at Jefferies... Ross Stores (ROST) upgraded to Buy from Neutral at Buckingham.
08:17 EDTMDRXAllscripts upgraded on new order growth, valuation at Argus
Subscribe for More Information
07:37 EDTMDRXAllscripts upgraded to Buy from Hold at Argus
August 19, 2015
16:02 EDTMDRXAllscripts announces partnership with CoverMyMeds
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use